May 16 (SeeNews) - The net profit of Romanian state-controlled drug maker Antibiotice [BSE:ATB] shrank to 5.1 million lei ($1.5 million/1.2 million euro) in the first quarter of 2013 from 13.4 million lei a year earlier, the company said.